Hellmann expands healthcare logistics with new Dubai South hub Located in Dubai South’s Logistics District, the site has access to Jebel Ali Port via a bonded corridor and cargo terminals at Al Maktoum Airport.

Located in Dubai South’s Logistics District, the site has access to Jebel Ali Port via a bonded corridor and cargo terminals at #AlMaktoumAirport.

#HellmannWorldwideLogistics #DubaiSouth #JebelAliPort #healthcare #healthcarelogistics #pharma #MiddleEast #pharmaceuticals #medicalproducts

The Applicator is a single-use, sterile medical applicator prefilled with chlorhexidine gluconate solution. It is designed for effective skin antisepsis prior to injections, venipuncture, minor surgical procedures, and catheter insertion.

#ChlorhexidineGluconate #MedicalProducts #SkinAntisepsis

APIL calls for national register of medical products The campaign organisation is calling for tougher regulations governing the use of medical products in the UK to prevent health scandals like pelvic mesh implants.

The Association of Personal Injury Lawyers (APIL) is calling for tougher regulations governing the use of medical products in the UK to prevent health scandals like pelvic mesh implants.

healthcaretoday.com/article/apil...

#healthcare #medicalproducts #pelvicmesh #patientsafety

African Nations Pledge To Boost Local Manufacturing Of Medical Products MOMBASA, Kenya, Nov 12 (NNN-KBC) – African nations, yesterday, agreed to strengthen collaboration in medical product research, development, and regulation, to boost local manufacturing and reduce dependence on imports. The seventh biennial Scientific Conference on Medical Products Regulation in Africa (SCoMRA VII), was held in Kenya’s coastal city of Mombasa, with delegates reflecting on the […]

African Nations Pledge To Boost Local Manufacturing Of Medical Products #AfricanNations #LocalManufacturing #MedicalProducts #SCoMRA #HealthcareInnovation

Asker Healthcare continues acquisition spree After its recent acquisition of Health Net Connections, the Swedish group adds endoscopic surgery specialists Novus Med to its roster.

Sweden’s provider of medical products and solutions Asker Healthcare Group continues its acquisition spree in the UK. It has added endoscopic surgery specialists novus med to the group.

healthcaretoday.com/article/aske...

#healthcare #medicalproducts #endoscopicsurgery

Substandard and falsified medical products training toolkit #: Title #

Have you seen the new open-access the @WHO Training Toolkit on #Substandard and #Falsified #MedicalProducts designed to support design and implementation of #SFMP training
View here: www.who.int/tools/substa...
Find out about out work on #MedicineQuality www.iddo.org/research-the...

Asker Healthcare acquires Health Net Connections The acquisition by the Swedish firm both strengthens its position and allows it to expand within ultrasound imaging and reporting software into the UK market.

Sweden’s provider of medical products and solutions Asker Healthcare Group has acquired British healthcare software firm Health Net Connections. It has taken 100% of the shares in the company.

healthcaretoday.com/article/aske...

#healthcare #medicalproducts #software #solutions

News that beagles, as seen in this file photo, were being used by medical researchers in London, Ont., for a study that saw heart attacks being induced for up to three hours at a time has renewed the spotlight on animal testing in Canada. (PETA)

Guinea pigs, rats, mice and rabbits are historically some of the most commonly used animals for testing. (Brian Gunn/Animal Alliance of Canada )

#MarkCarney & the @liberalparty.bsky.social fail to bring a real change to #AnimalWelfare

Federal government adopts new strategy to reduce #AnimalTesting
Strategy would affect testing of #chemicals BUT not #drugs or #medicalproducts

#Cdnpoli #AnimalCruelty
#AnimalRights

www.cbc.ca/news/politic...

Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit (Reuters) -Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts’ estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions. Shares of the medical products maker fell about 11% in premarket trading. Baxter (NYSE:BAX) now expects 2025 adjusted profit between $2.42 and $2.52 per share, down from its prior forecast of $2.47 to $2.55 per share. Analysts had expected $2.52 per share. The company lowered its forecast due to "potential downside risks" primarily affecting its medical products and therapies segment, following stagnant sales in the unit for the quarter. Hurricane Helene damaged Baxter’s North Cove, North Carolina manufacturing site, affecting IV solution production and prompting hospitals to conserve fluids due to supply disruption. The hurricane also resulted in additional costs for remediation, air freight and other expenses for the company. "Softness in demand for IV solutions due to fluid conservation efforts enacted post Hurricane Helene partially offset the segment’s growth in the quarter," the company said. Baxter said it has fully restocked IV solutions and lifted all supply limits for products made at its North Carolina facility. Its pharmaceuticals business also struggled, with injectable drug sales declining 1% amid difficult comparison with the prior year due to "timing of a government order", while anesthesia sales fell by low double digits globally. Baxter’s medical products and therapies unit posted quarterly sales of $1.32 billion, while its pharmaceuticals unit achieved $612 million in sales. The company earned 59 cents per share on an adjusted basis in the quarter, compared with estimates of 61 cents. Revenue came in at $2.81 billion, just shy of expectations of $2.82 billion.

Click Subscribe #Baxter #StockMarket #HurricaneImpact #MedicalProducts #ForecastCut

The Possible Demise of User Fees: Existential Threats Require Outside-the-Box Thinking — FDA Matters Last Thursday, Alec Gaffney of AgencyIQ declared “…the future of FDA’s user fee programs is in extreme jeopardy” ( here ). Alec has a well-deserved reputation as one of the best FDA analysts. Alec t...

The latest from The Grossman FDA Report:
The Possible Demise of User Fees: Existential Threats Demand Fresh Thinking

www.fdamatters.com/fdamatters/t...

---

#FDA #FDAMatters #TheGrossmanFDAReport #FDApolicy #FDArif #rif #userfees #medicalproducts

The Possible Demise of User Fees: Existential Threats Require Outside-the-Box Thinking — FDA Matters Last Thursday, Alec Gaffney of AgencyIQ declared “…the future of FDA’s user fee programs is in extreme jeopardy” ( here ). Alec has a well-deserved reputation as one of the best FDA analysts. Alec t...

The latest from The Grossman FDA Report:
The Possible Demise of User Fees: Existential Threats Demand Fresh Thinking

www.fdamatters.com/fdamatters/t...

---

#FDA #FDAMatters #TheGrossmanFDAReport #FDApolicy #FDArif #rif #userfees #medicalproducts

Medical Disposables Market expected to reach US$1,169.584 billion by 2030 The global medical disposables market is projected to grow at a CAGR of 10.23% to reach a market size of US$1,169.584 billion by 2030.

🏥🔬 The #MedicalDisposables Market is Expanding! With rising demand for hygiene, #infectioncontrol, and single-use #medicalproducts, the industry is witnessing rapid growth. 🚀
www.knowledge-sourcing.com/resources/pr...
#Medical #healthcare #MedicalSupplies #pharmaceuticals #MarketTrends #Pharma

Healeye enables users to quickly and effortlessly perform Uveitis checkup tests, eliminating the need for frequent hospital visits, and bringing convenience to tracking their flare ups and prescribing correct treatment.

#productdesign #industrialdesign #medicalproducts #uveitis

An essential tool for those working on #quality of #medicalproducts! @iddonews.bsky.social

#regulation #medicalproducts #politicallegitimacy #medicinalcannabis #medicaldevices #abortion #TherapeuticGoodsAdministration #TGA #FDA #EMA

RT @PennyGleeson@mastodon.lawprofs.org
#Introduction I am an academic at Deakin Law School (Melbourne). I research #regulation and #publichealthlaw incl re #medicalproducts (#medicaldevices #pharmaceuticals) by #regulators like the #TGA #FDA and #EMA.
My research covers (1/3)